nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—PLA2G1B—atherosclerosis	0.25	0.635	CbGaD
Dexamethasone—NOS2—atherosclerosis	0.112	0.284	CbGaD
Dexamethasone—PTGS2—atherosclerosis	0.0321	0.0814	CbGaD
Dexamethasone—ABCB11—Rosuvastatin—atherosclerosis	0.0305	0.0716	CbGbCtD
Dexamethasone—ABCB11—Pravastatin—atherosclerosis	0.0277	0.0652	CbGbCtD
Dexamethasone—SLCO1A2—Rosuvastatin—atherosclerosis	0.0193	0.0454	CbGbCtD
Dexamethasone—SLCO1A2—Simvastatin—atherosclerosis	0.018	0.0422	CbGbCtD
Dexamethasone—SLCO1A2—Lovastatin—atherosclerosis	0.0176	0.0413	CbGbCtD
Dexamethasone—SLCO1A2—Pravastatin—atherosclerosis	0.0176	0.0413	CbGbCtD
Dexamethasone—ABCC2—Ezetimibe—atherosclerosis	0.016	0.0377	CbGbCtD
Dexamethasone—ABCC2—Simvastatin—atherosclerosis	0.0149	0.035	CbGbCtD
Dexamethasone—ABCC2—Pravastatin—atherosclerosis	0.0146	0.0343	CbGbCtD
Dexamethasone—ABCC2—Lovastatin—atherosclerosis	0.0146	0.0343	CbGbCtD
Dexamethasone—ABCG2—Rosuvastatin—atherosclerosis	0.0145	0.0341	CbGbCtD
Dexamethasone—ABCG2—Ezetimibe—atherosclerosis	0.0145	0.0341	CbGbCtD
Dexamethasone—ABCG2—Pravastatin—atherosclerosis	0.0132	0.031	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.00995	0.0234	CbGbCtD
Dexamethasone—CYP3A7—Simvastatin—atherosclerosis	0.00995	0.0234	CbGbCtD
Dexamethasone—CYP3A7—Lovastatin—atherosclerosis	0.00973	0.0229	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.00973	0.0229	CbGbCtD
Dexamethasone—CYP2B6—Simvastatin—atherosclerosis	0.00947	0.0223	CbGbCtD
Dexamethasone—CYP3A5—Rosuvastatin—atherosclerosis	0.00803	0.0189	CbGbCtD
Dexamethasone—CYP3A5—Simvastatin—atherosclerosis	0.00746	0.0175	CbGbCtD
Dexamethasone—CYP3A5—Pravastatin—atherosclerosis	0.0073	0.0172	CbGbCtD
Dexamethasone—CYP3A5—Lovastatin—atherosclerosis	0.0073	0.0172	CbGbCtD
Dexamethasone—CYP2C8—Simvastatin—atherosclerosis	0.00717	0.0169	CbGbCtD
Dexamethasone—CYP2C8—Lovastatin—atherosclerosis	0.00702	0.0165	CbGbCtD
Dexamethasone—CYP2C8—Pravastatin—atherosclerosis	0.00702	0.0165	CbGbCtD
Dexamethasone—CYP2C19—Rosuvastatin—atherosclerosis	0.00647	0.0152	CbGbCtD
Dexamethasone—CYP2C19—Simvastatin—atherosclerosis	0.00602	0.0141	CbGbCtD
Dexamethasone—CYP2C19—Lovastatin—atherosclerosis	0.00589	0.0138	CbGbCtD
Dexamethasone—CYP2D6—Niacin—atherosclerosis	0.00579	0.0136	CbGbCtD
Dexamethasone—CYP2C9—Rosuvastatin—atherosclerosis	0.00538	0.0127	CbGbCtD
Dexamethasone—ABCB1—Ezetimibe—atherosclerosis	0.00522	0.0123	CbGbCtD
Dexamethasone—CYP2C9—Simvastatin—atherosclerosis	0.005	0.0118	CbGbCtD
Dexamethasone—CYP2C9—Pravastatin—atherosclerosis	0.0049	0.0115	CbGbCtD
Dexamethasone—CYP2C9—Lovastatin—atherosclerosis	0.0049	0.0115	CbGbCtD
Dexamethasone—ABCB1—Simvastatin—atherosclerosis	0.00486	0.0114	CbGbCtD
Dexamethasone—ABCB1—Lovastatin—atherosclerosis	0.00475	0.0112	CbGbCtD
Dexamethasone—ABCB1—Pravastatin—atherosclerosis	0.00475	0.0112	CbGbCtD
Dexamethasone—CYP2D6—Simvastatin—atherosclerosis	0.00458	0.0108	CbGbCtD
Dexamethasone—CYP2D6—Pravastatin—atherosclerosis	0.00448	0.0105	CbGbCtD
Dexamethasone—CYP2D6—Lovastatin—atherosclerosis	0.00448	0.0105	CbGbCtD
Dexamethasone—CYP3A4—Ezetimibe—atherosclerosis	0.00313	0.00736	CbGbCtD
Dexamethasone—CYP3A4—Rosuvastatin—atherosclerosis	0.00313	0.00736	CbGbCtD
Dexamethasone—CYP3A4—Simvastatin—atherosclerosis	0.00291	0.00684	CbGbCtD
Dexamethasone—CYP3A4—Pravastatin—atherosclerosis	0.00285	0.00669	CbGbCtD
Dexamethasone—CYP3A4—Lovastatin—atherosclerosis	0.00285	0.00669	CbGbCtD
Dexamethasone—PLA2G1B—blood vessel—atherosclerosis	0.00137	0.0684	CbGeAlD
Dexamethasone—PGR—artery—atherosclerosis	0.000808	0.0404	CbGeAlD
Dexamethasone—PTGS2—leg—atherosclerosis	0.000737	0.0369	CbGeAlD
Dexamethasone—PLA2G1B—connective tissue—atherosclerosis	0.000701	0.0351	CbGeAlD
Dexamethasone—PTGS2—hindlimb—atherosclerosis	0.000658	0.0329	CbGeAlD
Dexamethasone—CYP3A43—liver—atherosclerosis	0.000639	0.0319	CbGeAlD
Dexamethasone—PGR—blood vessel—atherosclerosis	0.000629	0.0315	CbGeAlD
Dexamethasone—PLA2G1B—cardiovascular system—atherosclerosis	0.00061	0.0305	CbGeAlD
Dexamethasone—Myopathy—Niacin—atherosclerosis	0.000596	0.0086	CcSEcCtD
Dexamethasone—Hepatomegaly—Niacin—atherosclerosis	0.000591	0.00852	CcSEcCtD
Dexamethasone—Myopathy—Pravastatin—atherosclerosis	0.000587	0.00847	CcSEcCtD
Dexamethasone—PTGS2—appendage—atherosclerosis	0.000565	0.0282	CbGeAlD
Dexamethasone—Glaucoma—Niacin—atherosclerosis	0.000555	0.00801	CcSEcCtD
Dexamethasone—ANXA1—connective tissue—atherosclerosis	0.000536	0.0268	CbGeAlD
Dexamethasone—Necrosis—Niacin—atherosclerosis	0.000533	0.00769	CcSEcCtD
Dexamethasone—Tingling sensation—Niacin—atherosclerosis	0.00052	0.00751	CcSEcCtD
Dexamethasone—Cataract—Lovastatin—atherosclerosis	0.000511	0.00738	CcSEcCtD
Dexamethasone—Vasculitis—Lovastatin—atherosclerosis	0.000499	0.0072	CcSEcCtD
Dexamethasone—Vasculitis—Ezetimibe—atherosclerosis	0.000489	0.00706	CcSEcCtD
Dexamethasone—CYP17A1—connective tissue—atherosclerosis	0.000481	0.024	CbGeAlD
Dexamethasone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.000479	0.00692	CcSEcCtD
Dexamethasone—Cataract—Simvastatin—atherosclerosis	0.000478	0.0069	CcSEcCtD
Dexamethasone—ANXA1—cardiovascular system—atherosclerosis	0.000467	0.0233	CbGeAlD
Dexamethasone—Vasculitis—Simvastatin—atherosclerosis	0.000466	0.00673	CcSEcCtD
Dexamethasone—CYP4A11—liver—atherosclerosis	0.000455	0.0228	CbGeAlD
Dexamethasone—Injury—Rosuvastatin—atherosclerosis	0.000454	0.00655	CcSEcCtD
Dexamethasone—CYP11A1—connective tissue—atherosclerosis	0.000447	0.0224	CbGeAlD
Dexamethasone—Cataract—Pravastatin—atherosclerosis	0.000432	0.00624	CcSEcCtD
Dexamethasone—Vasculitis—Pravastatin—atherosclerosis	0.000422	0.00609	CcSEcCtD
Dexamethasone—Dermatitis contact—Niacin—atherosclerosis	0.000413	0.00596	CcSEcCtD
Dexamethasone—ANXA1—adipose tissue—atherosclerosis	0.000411	0.0206	CbGeAlD
Dexamethasone—Betamethasone—PLA2G1B—atherosclerosis	0.000408	0.575	CrCbGaD
Dexamethasone—PTGS2—artery—atherosclerosis	0.000404	0.0202	CbGeAlD
Dexamethasone—Skin exfoliation—Niacin—atherosclerosis	0.000399	0.00576	CcSEcCtD
Dexamethasone—Fluid retention—Niacin—atherosclerosis	0.000397	0.00573	CcSEcCtD
Dexamethasone—Neuropathy—Pravastatin—atherosclerosis	0.000386	0.00558	CcSEcCtD
Dexamethasone—Injury—Lovastatin—atherosclerosis	0.000384	0.00555	CcSEcCtD
Dexamethasone—Oesophagitis—Niacin—atherosclerosis	0.000382	0.00551	CcSEcCtD
Dexamethasone—Diabetes mellitus—Simvastatin—atherosclerosis	0.00038	0.00548	CcSEcCtD
Dexamethasone—Muscular weakness—Rosuvastatin—atherosclerosis	0.000368	0.00531	CcSEcCtD
Dexamethasone—Diabetes mellitus—Niacin—atherosclerosis	0.000349	0.00504	CcSEcCtD
Dexamethasone—NR3C2—connective tissue—atherosclerosis	0.000347	0.0174	CbGeAlD
Dexamethasone—CYP11A1—adipose tissue—atherosclerosis	0.000343	0.0172	CbGeAlD
Dexamethasone—PTGS2—endothelium—atherosclerosis	0.000341	0.017	CbGeAlD
Dexamethasone—Injury—Pravastatin—atherosclerosis	0.000325	0.00469	CcSEcCtD
Dexamethasone—PGR—connective tissue—atherosclerosis	0.000323	0.0161	CbGeAlD
Dexamethasone—Dermatitis bullous—Niacin—atherosclerosis	0.000317	0.00458	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000315	0.00455	CcSEcCtD
Dexamethasone—PTGS2—blood vessel—atherosclerosis	0.000314	0.0157	CbGeAlD
Dexamethasone—Muscular weakness—Ezetimibe—atherosclerosis	0.000306	0.00441	CcSEcCtD
Dexamethasone—NR3C2—cardiovascular system—atherosclerosis	0.000302	0.0151	CbGeAlD
Dexamethasone—Migraine—Niacin—atherosclerosis	0.000299	0.00431	CcSEcCtD
Dexamethasone—Affect lability—Pravastatin—atherosclerosis	0.000294	0.00424	CcSEcCtD
Dexamethasone—ABCB11—liver—atherosclerosis	0.000293	0.0147	CbGeAlD
Dexamethasone—Muscular weakness—Simvastatin—atherosclerosis	0.000291	0.00421	CcSEcCtD
Dexamethasone—CYP19A1—connective tissue—atherosclerosis	0.00029	0.0145	CbGeAlD
Dexamethasone—ANXA1—liver—atherosclerosis	0.000289	0.0144	CbGeAlD
Dexamethasone—CYP3A7—liver—atherosclerosis	0.000287	0.0143	CbGeAlD
Dexamethasone—CYP2A6—adipose tissue—atherosclerosis	0.000284	0.0142	CbGeAlD
Dexamethasone—Mood swings—Pravastatin—atherosclerosis	0.000283	0.00408	CcSEcCtD
Dexamethasone—PGR—cardiovascular system—atherosclerosis	0.000281	0.014	CbGeAlD
Dexamethasone—Dry skin—Niacin—atherosclerosis	0.000278	0.00401	CcSEcCtD
Dexamethasone—Dry skin—Pravastatin—atherosclerosis	0.000274	0.00395	CcSEcCtD
Dexamethasone—CYP1B1—connective tissue—atherosclerosis	0.000272	0.0136	CbGeAlD
Dexamethasone—Muscular weakness—Niacin—atherosclerosis	0.000268	0.00386	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000267	0.00385	CcSEcCtD
Dexamethasone—NR3C2—adipose tissue—atherosclerosis	0.000266	0.0133	CbGeAlD
Dexamethasone—Muscular weakness—Pravastatin—atherosclerosis	0.000264	0.0038	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000262	0.00378	CcSEcCtD
Dexamethasone—CYP17A1—liver—atherosclerosis	0.000259	0.0129	CbGeAlD
Dexamethasone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000258	0.00372	CcSEcCtD
Dexamethasone—Sweating increased—Pravastatin—atherosclerosis	0.000252	0.00363	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00025	0.0036	CcSEcCtD
Dexamethasone—PGR—adipose tissue—atherosclerosis	0.000248	0.0124	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000244	0.0122	CbGeAlD
Dexamethasone—CYP1B1—cardiovascular system—atherosclerosis	0.000236	0.0118	CbGeAlD
Dexamethasone—Weight increased—Pravastatin—atherosclerosis	0.000235	0.00339	CcSEcCtD
Dexamethasone—Weight decreased—Pravastatin—atherosclerosis	0.000234	0.00337	CcSEcCtD
Dexamethasone—Angioedema—Rosuvastatin—atherosclerosis	0.000229	0.00331	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000227	0.00328	CcSEcCtD
Dexamethasone—Myocardial infarction—Pravastatin—atherosclerosis	0.000226	0.00326	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000226	0.00326	CcSEcCtD
Dexamethasone—CYP19A1—adipose tissue—atherosclerosis	0.000223	0.0111	CbGeAlD
Dexamethasone—Angiopathy—Ezetimibe—atherosclerosis	0.000218	0.00314	CcSEcCtD
Dexamethasone—Alopecia—Lovastatin—atherosclerosis	0.000216	0.00312	CcSEcCtD
Dexamethasone—Myalgia—Rosuvastatin—atherosclerosis	0.000214	0.00308	CcSEcCtD
Dexamethasone—Alopecia—Ezetimibe—atherosclerosis	0.000212	0.00306	CcSEcCtD
Dexamethasone—Haemoglobin—Niacin—atherosclerosis	0.000211	0.00305	CcSEcCtD
Dexamethasone—Haemorrhage—Niacin—atherosclerosis	0.00021	0.00303	CcSEcCtD
Dexamethasone—Erythema—Ezetimibe—atherosclerosis	0.000209	0.00301	CcSEcCtD
Dexamethasone—CYP1B1—adipose tissue—atherosclerosis	0.000208	0.0104	CbGeAlD
Dexamethasone—Infection—Rosuvastatin—atherosclerosis	0.000204	0.00294	CcSEcCtD
Dexamethasone—Visual impairment—Niacin—atherosclerosis	0.000202	0.00292	CcSEcCtD
Dexamethasone—Alopecia—Simvastatin—atherosclerosis	0.000202	0.00292	CcSEcCtD
Dexamethasone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000201	0.0029	CcSEcCtD
Dexamethasone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000201	0.0029	CcSEcCtD
Dexamethasone—CYP2A6—liver—atherosclerosis	0.000199	0.00997	CbGeAlD
Dexamethasone—Visual impairment—Pravastatin—atherosclerosis	0.000199	0.00287	CcSEcCtD
Dexamethasone—Erythema—Simvastatin—atherosclerosis	0.000199	0.00287	CcSEcCtD
Dexamethasone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000197	0.00285	CcSEcCtD
Dexamethasone—Eye disorder—Niacin—atherosclerosis	0.000196	0.00283	CcSEcCtD
Dexamethasone—ABCB1—blood vessel—atherosclerosis	0.000194	0.00972	CbGeAlD
Dexamethasone—Angioedema—Lovastatin—atherosclerosis	0.000194	0.00281	CcSEcCtD
Dexamethasone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000194	0.00279	CcSEcCtD
Dexamethasone—Malaise—Lovastatin—atherosclerosis	0.000192	0.00277	CcSEcCtD
Dexamethasone—Vertigo—Lovastatin—atherosclerosis	0.000191	0.00276	CcSEcCtD
Dexamethasone—Angioedema—Ezetimibe—atherosclerosis	0.000191	0.00275	CcSEcCtD
Dexamethasone—Angiopathy—Niacin—atherosclerosis	0.00019	0.00275	CcSEcCtD
Dexamethasone—Malaise—Ezetimibe—atherosclerosis	0.000188	0.00272	CcSEcCtD
Dexamethasone—Arrhythmia—Niacin—atherosclerosis	0.000188	0.00271	CcSEcCtD
Dexamethasone—NR3C2—liver—atherosclerosis	0.000187	0.00934	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000187	0.00269	CcSEcCtD
Dexamethasone—NR3C1—connective tissue—atherosclerosis	0.000186	0.00931	CbGeAlD
Dexamethasone—Alopecia—Niacin—atherosclerosis	0.000185	0.00268	CcSEcCtD
Dexamethasone—Insomnia—Rosuvastatin—atherosclerosis	0.000185	0.00267	CcSEcCtD
Dexamethasone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000185	0.00267	CcSEcCtD
Dexamethasone—Arrhythmia—Pravastatin—atherosclerosis	0.000185	0.00266	CcSEcCtD
Dexamethasone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000184	0.00266	CcSEcCtD
Dexamethasone—Erythema—Niacin—atherosclerosis	0.000183	0.00264	CcSEcCtD
Dexamethasone—Alopecia—Pravastatin—atherosclerosis	0.000183	0.00264	CcSEcCtD
Dexamethasone—Angioedema—Simvastatin—atherosclerosis	0.000182	0.00262	CcSEcCtD
Dexamethasone—Myalgia—Lovastatin—atherosclerosis	0.000181	0.00261	CcSEcCtD
Dexamethasone—Anxiety—Lovastatin—atherosclerosis	0.000181	0.00261	CcSEcCtD
Dexamethasone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00018	0.0026	CcSEcCtD
Dexamethasone—Hypertension—Ezetimibe—atherosclerosis	0.00018	0.0026	CcSEcCtD
Dexamethasone—Malaise—Simvastatin—atherosclerosis	0.000179	0.00259	CcSEcCtD
Dexamethasone—Discomfort—Lovastatin—atherosclerosis	0.000179	0.00258	CcSEcCtD
Dexamethasone—Vertigo—Simvastatin—atherosclerosis	0.000179	0.00258	CcSEcCtD
Dexamethasone—Myalgia—Ezetimibe—atherosclerosis	0.000178	0.00256	CcSEcCtD
Dexamethasone—Discomfort—Ezetimibe—atherosclerosis	0.000176	0.00253	CcSEcCtD
Dexamethasone—Pain—Rosuvastatin—atherosclerosis	0.000175	0.00253	CcSEcCtD
Dexamethasone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000174	0.00251	CcSEcCtD
Dexamethasone—Infection—Lovastatin—atherosclerosis	0.000173	0.00249	CcSEcCtD
Dexamethasone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00017	0.00246	CcSEcCtD
Dexamethasone—Thrombocytopenia—Lovastatin—atherosclerosis	0.00017	0.00245	CcSEcCtD
Dexamethasone—Myalgia—Simvastatin—atherosclerosis	0.000169	0.00245	CcSEcCtD
Dexamethasone—Infection—Ezetimibe—atherosclerosis	0.000169	0.00244	CcSEcCtD
Dexamethasone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000169	0.00244	CcSEcCtD
Dexamethasone—Anxiety—Simvastatin—atherosclerosis	0.000169	0.00244	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000168	0.00242	CcSEcCtD
Dexamethasone—Discomfort—Simvastatin—atherosclerosis	0.000167	0.00242	CcSEcCtD
Dexamethasone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000167	0.00241	CcSEcCtD
Dexamethasone—Angioedema—Niacin—atherosclerosis	0.000167	0.00241	CcSEcCtD
Dexamethasone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000167	0.00241	CcSEcCtD
Dexamethasone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000167	0.00241	CcSEcCtD
Dexamethasone—Anorexia—Lovastatin—atherosclerosis	0.000166	0.00239	CcSEcCtD
Dexamethasone—Angioedema—Pravastatin—atherosclerosis	0.000164	0.00237	CcSEcCtD
Dexamethasone—Vertigo—Niacin—atherosclerosis	0.000164	0.00237	CcSEcCtD
Dexamethasone—Syncope—Niacin—atherosclerosis	0.000164	0.00237	CcSEcCtD
Dexamethasone—Urticaria—Rosuvastatin—atherosclerosis	0.000163	0.00235	CcSEcCtD
Dexamethasone—Oedema—Simvastatin—atherosclerosis	0.000162	0.00234	CcSEcCtD
Dexamethasone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000162	0.00234	CcSEcCtD
Dexamethasone—CYP2B6—cardiovascular system—atherosclerosis	0.000162	0.00811	CbGeAlD
Dexamethasone—Malaise—Pravastatin—atherosclerosis	0.000162	0.00234	CcSEcCtD
Dexamethasone—NR3C1—cardiovascular system—atherosclerosis	0.000162	0.0081	CbGeAlD
Dexamethasone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000162	0.00234	CcSEcCtD
Dexamethasone—Vertigo—Pravastatin—atherosclerosis	0.000162	0.00233	CcSEcCtD
Dexamethasone—Infection—Simvastatin—atherosclerosis	0.000161	0.00233	CcSEcCtD
Dexamethasone—PTGS2—connective tissue—atherosclerosis	0.000161	0.00806	CbGeAlD
Dexamethasone—CYP2C9—cardiovascular system—atherosclerosis	0.000161	0.00804	CbGeAlD
Dexamethasone—Loss of consciousness—Niacin—atherosclerosis	0.000161	0.00232	CcSEcCtD
Dexamethasone—SLCO1A2—liver—atherosclerosis	0.00016	0.00801	CbGeAlD
Dexamethasone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000159	0.0023	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000158	0.00228	CcSEcCtD
Dexamethasone—Insomnia—Lovastatin—atherosclerosis	0.000157	0.00227	CcSEcCtD
Dexamethasone—CYP19A1—liver—atherosclerosis	0.000156	0.00781	CbGeAlD
Dexamethasone—Paraesthesia—Lovastatin—atherosclerosis	0.000156	0.00225	CcSEcCtD
Dexamethasone—Myalgia—Niacin—atherosclerosis	0.000156	0.00225	CcSEcCtD
Dexamethasone—Hypertension—Pravastatin—atherosclerosis	0.000155	0.00224	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000155	0.00224	CcSEcCtD
Dexamethasone—ABCG2—adipose tissue—atherosclerosis	0.000155	0.00776	CbGeAlD
Dexamethasone—Anorexia—Simvastatin—atherosclerosis	0.000155	0.00223	CcSEcCtD
Dexamethasone—Insomnia—Ezetimibe—atherosclerosis	0.000154	0.00222	CcSEcCtD
Dexamethasone—Myalgia—Pravastatin—atherosclerosis	0.000153	0.00221	CcSEcCtD
Dexamethasone—Paraesthesia—Ezetimibe—atherosclerosis	0.000153	0.00221	CcSEcCtD
Dexamethasone—Dyspepsia—Lovastatin—atherosclerosis	0.000153	0.00221	CcSEcCtD
Dexamethasone—Anxiety—Pravastatin—atherosclerosis	0.000153	0.0022	CcSEcCtD
Dexamethasone—CYP2E1—cardiovascular system—atherosclerosis	0.000152	0.00762	CbGeAlD
Dexamethasone—Discomfort—Pravastatin—atherosclerosis	0.000151	0.00218	CcSEcCtD
Dexamethasone—Decreased appetite—Lovastatin—atherosclerosis	0.000151	0.00218	CcSEcCtD
Dexamethasone—Dyspepsia—Ezetimibe—atherosclerosis	0.00015	0.00216	CcSEcCtD
Dexamethasone—Fatigue—Lovastatin—atherosclerosis	0.00015	0.00216	CcSEcCtD
Dexamethasone—ABCC2—liver—atherosclerosis	0.000149	0.00746	CbGeAlD
Dexamethasone—Oedema—Niacin—atherosclerosis	0.000149	0.00215	CcSEcCtD
Dexamethasone—Anaphylactic shock—Niacin—atherosclerosis	0.000149	0.00215	CcSEcCtD
Dexamethasone—Pain—Lovastatin—atherosclerosis	0.000148	0.00214	CcSEcCtD
Dexamethasone—Decreased appetite—Ezetimibe—atherosclerosis	0.000148	0.00214	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000148	0.00214	CcSEcCtD
Dexamethasone—CYP1A1—adipose tissue—atherosclerosis	0.000147	0.00736	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Asthenia—Rosuvastatin—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Insomnia—Simvastatin—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Oedema—Pravastatin—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Fatigue—Ezetimibe—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—Shock—Niacin—atherosclerosis	0.000147	0.00212	CcSEcCtD
Dexamethasone—CYP1B1—liver—atherosclerosis	0.000146	0.00731	CbGeAlD
Dexamethasone—Infection—Pravastatin—atherosclerosis	0.000146	0.00211	CcSEcCtD
Dexamethasone—Paraesthesia—Simvastatin—atherosclerosis	0.000146	0.00211	CcSEcCtD
Dexamethasone—Pain—Ezetimibe—atherosclerosis	0.000146	0.0021	CcSEcCtD
Dexamethasone—Tachycardia—Niacin—atherosclerosis	0.000146	0.0021	CcSEcCtD
Dexamethasone—Pruritus—Rosuvastatin—atherosclerosis	0.000145	0.00209	CcSEcCtD
Dexamethasone—Hyperhidrosis—Niacin—atherosclerosis	0.000144	0.00208	CcSEcCtD
Dexamethasone—CYP3A5—adipose tissue—atherosclerosis	0.000144	0.0072	CbGeAlD
Dexamethasone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000144	0.00208	CcSEcCtD
Dexamethasone—Feeling abnormal—Lovastatin—atherosclerosis	0.000143	0.00207	CcSEcCtD
Dexamethasone—Dyspepsia—Simvastatin—atherosclerosis	0.000143	0.00206	CcSEcCtD
Dexamethasone—NR3C1—adipose tissue—atherosclerosis	0.000143	0.00714	CbGeAlD
Dexamethasone—Anorexia—Niacin—atherosclerosis	0.000142	0.00205	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000142	0.00205	CcSEcCtD
Dexamethasone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000142	0.00205	CcSEcCtD
Dexamethasone—Decreased appetite—Simvastatin—atherosclerosis	0.000141	0.00204	CcSEcCtD
Dexamethasone—Feeling abnormal—Ezetimibe—atherosclerosis	0.00014	0.00203	CcSEcCtD
Dexamethasone—PTGS2—cardiovascular system—atherosclerosis	0.00014	0.00701	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00014	0.00202	CcSEcCtD
Dexamethasone—Diarrhoea—Rosuvastatin—atherosclerosis	0.00014	0.00202	CcSEcCtD
Dexamethasone—Fatigue—Simvastatin—atherosclerosis	0.00014	0.00202	CcSEcCtD
Dexamethasone—Anorexia—Pravastatin—atherosclerosis	0.00014	0.00202	CcSEcCtD
Dexamethasone—Hypotension—Niacin—atherosclerosis	0.000139	0.00201	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000139	0.00201	CcSEcCtD
Dexamethasone—Pain—Simvastatin—atherosclerosis	0.000139	0.002	CcSEcCtD
Dexamethasone—Urticaria—Lovastatin—atherosclerosis	0.000138	0.00199	CcSEcCtD
Dexamethasone—Abdominal pain—Lovastatin—atherosclerosis	0.000137	0.00198	CcSEcCtD
Dexamethasone—Body temperature increased—Lovastatin—atherosclerosis	0.000137	0.00198	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000136	0.00196	CcSEcCtD
Dexamethasone—Dizziness—Rosuvastatin—atherosclerosis	0.000135	0.00196	CcSEcCtD
Dexamethasone—Urticaria—Ezetimibe—atherosclerosis	0.000135	0.00195	CcSEcCtD
Dexamethasone—Insomnia—Niacin—atherosclerosis	0.000135	0.00195	CcSEcCtD
Dexamethasone—Body temperature increased—Ezetimibe—atherosclerosis	0.000135	0.00194	CcSEcCtD
Dexamethasone—Abdominal pain—Ezetimibe—atherosclerosis	0.000135	0.00194	CcSEcCtD
Dexamethasone—Fluoxymesterone—ESR1—atherosclerosis	0.000134	0.189	CrCbGaD
Dexamethasone—Paraesthesia—Niacin—atherosclerosis	0.000134	0.00193	CcSEcCtD
Dexamethasone—Feeling abnormal—Simvastatin—atherosclerosis	0.000134	0.00193	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000134	0.00193	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000133	0.00192	CcSEcCtD
Dexamethasone—Insomnia—Pravastatin—atherosclerosis	0.000133	0.00192	CcSEcCtD
Dexamethasone—Paraesthesia—Pravastatin—atherosclerosis	0.000132	0.0019	CcSEcCtD
Dexamethasone—Dyspepsia—Niacin—atherosclerosis	0.000131	0.00189	CcSEcCtD
Dexamethasone—Decreased appetite—Niacin—atherosclerosis	0.00013	0.00187	CcSEcCtD
Dexamethasone—Dyspepsia—Pravastatin—atherosclerosis	0.000129	0.00187	CcSEcCtD
Dexamethasone—Rash—Rosuvastatin—atherosclerosis	0.000129	0.00186	CcSEcCtD
Dexamethasone—Dermatitis—Rosuvastatin—atherosclerosis	0.000129	0.00186	CcSEcCtD
Dexamethasone—Urticaria—Simvastatin—atherosclerosis	0.000129	0.00186	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000129	0.00186	CcSEcCtD
Dexamethasone—Body temperature increased—Simvastatin—atherosclerosis	0.000128	0.00185	CcSEcCtD
Dexamethasone—Abdominal pain—Simvastatin—atherosclerosis	0.000128	0.00185	CcSEcCtD
Dexamethasone—Headache—Rosuvastatin—atherosclerosis	0.000128	0.00185	CcSEcCtD
Dexamethasone—CYP2C19—liver—atherosclerosis	0.000128	0.00641	CbGeAlD
Dexamethasone—Decreased appetite—Pravastatin—atherosclerosis	0.000128	0.00184	CcSEcCtD
Dexamethasone—Pain—Niacin—atherosclerosis	0.000128	0.00184	CcSEcCtD
Dexamethasone—Fatigue—Pravastatin—atherosclerosis	0.000127	0.00183	CcSEcCtD
Dexamethasone—Pain—Pravastatin—atherosclerosis	0.000126	0.00181	CcSEcCtD
Dexamethasone—Asthenia—Lovastatin—atherosclerosis	0.000125	0.0018	CcSEcCtD
Dexamethasone—PTGS2—adipose tissue—atherosclerosis	0.000124	0.00618	CbGeAlD
Dexamethasone—Pruritus—Lovastatin—atherosclerosis	0.000123	0.00177	CcSEcCtD
Dexamethasone—Asthenia—Ezetimibe—atherosclerosis	0.000122	0.00176	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Niacin—atherosclerosis	0.000122	0.00176	CcSEcCtD
Dexamethasone—Nausea—Rosuvastatin—atherosclerosis	0.000122	0.00176	CcSEcCtD
Dexamethasone—Feeling abnormal—Pravastatin—atherosclerosis	0.000121	0.00175	CcSEcCtD
Dexamethasone—Pruritus—Ezetimibe—atherosclerosis	0.00012	0.00174	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00012	0.00173	CcSEcCtD
Dexamethasone—Diarrhoea—Lovastatin—atherosclerosis	0.000119	0.00171	CcSEcCtD
Dexamethasone—Urticaria—Niacin—atherosclerosis	0.000118	0.00171	CcSEcCtD
Dexamethasone—Abdominal pain—Niacin—atherosclerosis	0.000118	0.0017	CcSEcCtD
Dexamethasone—Body temperature increased—Niacin—atherosclerosis	0.000118	0.0017	CcSEcCtD
Dexamethasone—Urticaria—Pravastatin—atherosclerosis	0.000117	0.00168	CcSEcCtD
Dexamethasone—Asthenia—Simvastatin—atherosclerosis	0.000117	0.00168	CcSEcCtD
Dexamethasone—Diarrhoea—Ezetimibe—atherosclerosis	0.000117	0.00168	CcSEcCtD
Dexamethasone—Abdominal pain—Pravastatin—atherosclerosis	0.000116	0.00168	CcSEcCtD
Dexamethasone—Body temperature increased—Pravastatin—atherosclerosis	0.000116	0.00168	CcSEcCtD
Dexamethasone—Pruritus—Simvastatin—atherosclerosis	0.000115	0.00166	CcSEcCtD
Dexamethasone—Dizziness—Lovastatin—atherosclerosis	0.000115	0.00166	CcSEcCtD
Dexamethasone—Dizziness—Ezetimibe—atherosclerosis	0.000113	0.00163	CcSEcCtD
Dexamethasone—CYP2C8—liver—atherosclerosis	0.000112	0.00559	CbGeAlD
Dexamethasone—Diarrhoea—Simvastatin—atherosclerosis	0.000111	0.0016	CcSEcCtD
Dexamethasone—Vomiting—Lovastatin—atherosclerosis	0.00011	0.00159	CcSEcCtD
Dexamethasone—Rash—Lovastatin—atherosclerosis	0.000109	0.00158	CcSEcCtD
Dexamethasone—Dermatitis—Lovastatin—atherosclerosis	0.000109	0.00158	CcSEcCtD
Dexamethasone—ABCG2—liver—atherosclerosis	0.000109	0.00544	CbGeAlD
Dexamethasone—Headache—Lovastatin—atherosclerosis	0.000109	0.00157	CcSEcCtD
Dexamethasone—Vomiting—Ezetimibe—atherosclerosis	0.000108	0.00156	CcSEcCtD
Dexamethasone—Dizziness—Simvastatin—atherosclerosis	0.000107	0.00155	CcSEcCtD
Dexamethasone—Rash—Ezetimibe—atherosclerosis	0.000107	0.00155	CcSEcCtD
Dexamethasone—Dermatitis—Ezetimibe—atherosclerosis	0.000107	0.00155	CcSEcCtD
Dexamethasone—Asthenia—Niacin—atherosclerosis	0.000107	0.00154	CcSEcCtD
Dexamethasone—Headache—Ezetimibe—atherosclerosis	0.000107	0.00154	CcSEcCtD
Dexamethasone—Pruritus—Niacin—atherosclerosis	0.000106	0.00152	CcSEcCtD
Dexamethasone—Asthenia—Pravastatin—atherosclerosis	0.000105	0.00152	CcSEcCtD
Dexamethasone—Pruritus—Pravastatin—atherosclerosis	0.000104	0.0015	CcSEcCtD
Dexamethasone—CYP1A1—liver—atherosclerosis	0.000103	0.00516	CbGeAlD
Dexamethasone—Vomiting—Simvastatin—atherosclerosis	0.000103	0.00149	CcSEcCtD
Dexamethasone—Nausea—Lovastatin—atherosclerosis	0.000103	0.00149	CcSEcCtD
Dexamethasone—Rash—Simvastatin—atherosclerosis	0.000102	0.00148	CcSEcCtD
Dexamethasone—Dermatitis—Simvastatin—atherosclerosis	0.000102	0.00148	CcSEcCtD
Dexamethasone—Diarrhoea—Niacin—atherosclerosis	0.000102	0.00147	CcSEcCtD
Dexamethasone—Headache—Simvastatin—atherosclerosis	0.000102	0.00147	CcSEcCtD
Dexamethasone—Nausea—Ezetimibe—atherosclerosis	0.000101	0.00146	CcSEcCtD
Dexamethasone—CYP3A5—liver—atherosclerosis	0.000101	0.00505	CbGeAlD
Dexamethasone—Diarrhoea—Pravastatin—atherosclerosis	0.0001	0.00145	CcSEcCtD
Dexamethasone—CYP2B6—liver—atherosclerosis	0.0001	0.00502	CbGeAlD
Dexamethasone—NR3C1—liver—atherosclerosis	0.0001	0.00501	CbGeAlD
Dexamethasone—CYP2C9—liver—atherosclerosis	9.94e-05	0.00497	CbGeAlD
Dexamethasone—Dizziness—Niacin—atherosclerosis	9.86e-05	0.00142	CcSEcCtD
Dexamethasone—Dizziness—Pravastatin—atherosclerosis	9.71e-05	0.0014	CcSEcCtD
Dexamethasone—Nausea—Simvastatin—atherosclerosis	9.65e-05	0.00139	CcSEcCtD
Dexamethasone—Vomiting—Niacin—atherosclerosis	9.48e-05	0.00137	CcSEcCtD
Dexamethasone—CYP2E1—liver—atherosclerosis	9.42e-05	0.00471	CbGeAlD
Dexamethasone—Rash—Niacin—atherosclerosis	9.4e-05	0.00136	CcSEcCtD
Dexamethasone—Dermatitis—Niacin—atherosclerosis	9.39e-05	0.00136	CcSEcCtD
Dexamethasone—Headache—Niacin—atherosclerosis	9.34e-05	0.00135	CcSEcCtD
Dexamethasone—Vomiting—Pravastatin—atherosclerosis	9.34e-05	0.00135	CcSEcCtD
Dexamethasone—Rash—Pravastatin—atherosclerosis	9.26e-05	0.00134	CcSEcCtD
Dexamethasone—Dermatitis—Pravastatin—atherosclerosis	9.25e-05	0.00134	CcSEcCtD
Dexamethasone—Headache—Pravastatin—atherosclerosis	9.2e-05	0.00133	CcSEcCtD
Dexamethasone—Nausea—Niacin—atherosclerosis	8.86e-05	0.00128	CcSEcCtD
Dexamethasone—Nausea—Pravastatin—atherosclerosis	8.72e-05	0.00126	CcSEcCtD
Dexamethasone—ABCB1—cardiovascular system—atherosclerosis	8.67e-05	0.00434	CbGeAlD
Dexamethasone—PTGS2—liver—atherosclerosis	8.67e-05	0.00434	CbGeAlD
Dexamethasone—ABCB1—adipose tissue—atherosclerosis	7.65e-05	0.00382	CbGeAlD
Dexamethasone—CYP3A4—liver—atherosclerosis	7.58e-05	0.00379	CbGeAlD
Dexamethasone—CYP2D6—liver—atherosclerosis	7.46e-05	0.00373	CbGeAlD
Dexamethasone—Triamcinolone—PTGS2—atherosclerosis	6.38e-05	0.0899	CrCbGaD
Dexamethasone—ABCB1—liver—atherosclerosis	5.36e-05	0.00268	CbGeAlD
Dexamethasone—Betamethasone—PTGS2—atherosclerosis	5.23e-05	0.0736	CrCbGaD
Dexamethasone—Prednisone—ALB—atherosclerosis	5.16e-05	0.0727	CrCbGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—atherosclerosis	1.97e-06	2.18e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—INS—atherosclerosis	1.97e-06	2.17e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOB—atherosclerosis	1.96e-06	2.17e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.96e-06	2.16e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GPX1—atherosclerosis	1.94e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GPX1—atherosclerosis	1.94e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CD36—atherosclerosis	1.93e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—NOS3—atherosclerosis	1.91e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.91e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ABCA1—atherosclerosis	1.91e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.9e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LPA—atherosclerosis	1.9e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTHFR—atherosclerosis	1.9e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CD36—atherosclerosis	1.89e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CD36—atherosclerosis	1.89e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.88e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—LPL—atherosclerosis	1.88e-06	2.07e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARA—atherosclerosis	1.87e-06	2.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BGN—atherosclerosis	1.84e-06	2.04e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—atherosclerosis	1.84e-06	2.03e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GPX1—atherosclerosis	1.83e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.83e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOA5—atherosclerosis	1.83e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—atherosclerosis	1.83e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ALB—atherosclerosis	1.82e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—atherosclerosis	1.82e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AGT—atherosclerosis	1.81e-06	2e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—atherosclerosis	1.81e-06	2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—INS—atherosclerosis	1.81e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.81e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ALB—atherosclerosis	1.8e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—INS—atherosclerosis	1.8e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOB—atherosclerosis	1.8e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.8e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARA—atherosclerosis	1.79e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.79e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—atherosclerosis	1.79e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.79e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.78e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CD36—atherosclerosis	1.78e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOE—atherosclerosis	1.77e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARA—atherosclerosis	1.76e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.76e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CAV1—atherosclerosis	1.76e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARA—atherosclerosis	1.75e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.75e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOA1—atherosclerosis	1.75e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—atherosclerosis	1.75e-06	1.93e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—NOS3—atherosclerosis	1.74e-06	1.92e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AGT—atherosclerosis	1.74e-06	1.92e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK3—atherosclerosis	1.73e-06	1.91e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—NOS3—atherosclerosis	1.73e-06	1.91e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—LPL—atherosclerosis	1.72e-06	1.9e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOE—atherosclerosis	1.7e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AGT—atherosclerosis	1.7e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AGT—atherosclerosis	1.7e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.7e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—atherosclerosis	1.69e-06	1.87e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CAV1—atherosclerosis	1.69e-06	1.86e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOA1—atherosclerosis	1.68e-06	1.86e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.68e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GPX1—atherosclerosis	1.68e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—atherosclerosis	1.68e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOE—atherosclerosis	1.67e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOE—atherosclerosis	1.66e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SERPINE1—atherosclerosis	1.66e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARA—atherosclerosis	1.66e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—atherosclerosis	1.65e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CAV1—atherosclerosis	1.65e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CAV1—atherosclerosis	1.65e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOA1—atherosclerosis	1.65e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOA1—atherosclerosis	1.65e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HMOX1—atherosclerosis	1.64e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CD36—atherosclerosis	1.63e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOB—atherosclerosis	1.61e-06	1.78e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AGT—atherosclerosis	1.61e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.6e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—atherosclerosis	1.59e-06	1.76e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS3—atherosclerosis	1.59e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—NOS3—atherosclerosis	1.58e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—atherosclerosis	1.58e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOE—atherosclerosis	1.57e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOB—atherosclerosis	1.57e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.56e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAV1—atherosclerosis	1.56e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOA1—atherosclerosis	1.55e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.55e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.54e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—atherosclerosis	1.54e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.54e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—LPL—atherosclerosis	1.54e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.54e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.53e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—atherosclerosis	1.53e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.52e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARA—atherosclerosis	1.52e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—INS—atherosclerosis	1.51e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.51e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—atherosclerosis	1.51e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.51e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.5e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.5e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—LPL—atherosclerosis	1.5e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GPX1—atherosclerosis	1.5e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.49e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—atherosclerosis	1.48e-06	1.64e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOB—atherosclerosis	1.48e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AGT—atherosclerosis	1.47e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOB—atherosclerosis	1.47e-06	1.62e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GPX1—atherosclerosis	1.46e-06	1.62e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CETP—atherosclerosis	1.46e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CD36—atherosclerosis	1.46e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—INS—atherosclerosis	1.45e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—atherosclerosis	1.45e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—atherosclerosis	1.45e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.45e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOE—atherosclerosis	1.44e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.44e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAV1—atherosclerosis	1.43e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.43e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOA1—atherosclerosis	1.43e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—INS—atherosclerosis	1.42e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CD36—atherosclerosis	1.42e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—INS—atherosclerosis	1.42e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.42e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—LPL—atherosclerosis	1.41e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—LPL—atherosclerosis	1.4e-06	1.55e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.4e-06	1.54e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—atherosclerosis	1.39e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.38e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—atherosclerosis	1.38e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GPX1—atherosclerosis	1.38e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—atherosclerosis	1.37e-06	1.51e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GPX1—atherosclerosis	1.37e-06	1.51e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—atherosclerosis	1.36e-06	1.51e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARA—atherosclerosis	1.36e-06	1.5e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—atherosclerosis	1.35e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—INS—atherosclerosis	1.34e-06	1.48e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CD36—atherosclerosis	1.34e-06	1.48e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—atherosclerosis	1.33e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CD36—atherosclerosis	1.33e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NOS3—atherosclerosis	1.33e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARA—atherosclerosis	1.32e-06	1.46e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.32e-06	1.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AGT—atherosclerosis	1.31e-06	1.45e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—atherosclerosis	1.31e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—atherosclerosis	1.3e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.3e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOE—atherosclerosis	1.29e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AGT—atherosclerosis	1.28e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NOS3—atherosclerosis	1.28e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAV1—atherosclerosis	1.28e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOA1—atherosclerosis	1.27e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.27e-06	1.4e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—atherosclerosis	1.26e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.26e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOE—atherosclerosis	1.26e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—atherosclerosis	1.26e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NOS3—atherosclerosis	1.25e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARA—atherosclerosis	1.25e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NOS3—atherosclerosis	1.25e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAV1—atherosclerosis	1.24e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOA1—atherosclerosis	1.24e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARA—atherosclerosis	1.24e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—INS—atherosclerosis	1.23e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—atherosclerosis	1.23e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—atherosclerosis	1.21e-06	1.34e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AGT—atherosclerosis	1.21e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AGT—atherosclerosis	1.2e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOE—atherosclerosis	1.18e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NOS3—atherosclerosis	1.18e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.18e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOE—atherosclerosis	1.17e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAV1—atherosclerosis	1.17e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOA1—atherosclerosis	1.17e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.17e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—atherosclerosis	1.16e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAV1—atherosclerosis	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOA1—atherosclerosis	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.14e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.14e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.13e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—atherosclerosis	1.13e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—atherosclerosis	1.13e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—atherosclerosis	1.12e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—INS—atherosclerosis	1.1e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—atherosclerosis	1.09e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—atherosclerosis	1.08e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NOS3—atherosclerosis	1.08e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—atherosclerosis	1.08e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—INS—atherosclerosis	1.07e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.07e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.06e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—atherosclerosis	1.05e-06	1.16e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—atherosclerosis	1.04e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—atherosclerosis	1.03e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—atherosclerosis	1.02e-06	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—INS—atherosclerosis	1.01e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—atherosclerosis	1.01e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.01e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—atherosclerosis	1.01e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—INS—atherosclerosis	1e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—atherosclerosis	9.88e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—atherosclerosis	9.84e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOB—atherosclerosis	9.67e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NOS3—atherosclerosis	9.64e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NOS3—atherosclerosis	9.41e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—atherosclerosis	9.41e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—atherosclerosis	9.27e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LPL—atherosclerosis	9.23e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—atherosclerosis	9.19e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—atherosclerosis	9.13e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPX1—atherosclerosis	9.01e-07	9.95e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NOS3—atherosclerosis	8.87e-07	9.8e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—atherosclerosis	8.82e-07	9.74e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—atherosclerosis	8.79e-07	9.72e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NOS3—atherosclerosis	8.79e-07	9.71e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD36—atherosclerosis	8.77e-07	9.69e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—atherosclerosis	8.61e-07	9.51e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—atherosclerosis	8.31e-07	9.18e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARA—atherosclerosis	8.16e-07	9.01e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—atherosclerosis	8.11e-07	8.96e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—atherosclerosis	8.04e-07	8.88e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—atherosclerosis	8e-07	8.84e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—atherosclerosis	7.93e-07	8.76e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AGT—atherosclerosis	7.9e-07	8.73e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—atherosclerosis	7.9e-07	8.73e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOE—atherosclerosis	7.74e-07	8.55e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAV1—atherosclerosis	7.67e-07	8.47e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOA1—atherosclerosis	7.65e-07	8.45e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—atherosclerosis	7.29e-07	8.05e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—atherosclerosis	7.27e-07	8.03e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.98e-07	7.72e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—atherosclerosis	6.74e-07	7.45e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—INS—atherosclerosis	6.61e-07	7.3e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—atherosclerosis	6.1e-07	6.74e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—atherosclerosis	6.06e-07	6.7e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—atherosclerosis	5.86e-07	6.48e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NOS3—atherosclerosis	5.8e-07	6.4e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—atherosclerosis	5.74e-07	6.35e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—atherosclerosis	5.73e-07	6.33e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—atherosclerosis	5.42e-07	5.98e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—atherosclerosis	5.3e-07	5.86e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—atherosclerosis	4.97e-07	5.49e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—atherosclerosis	4.43e-07	4.9e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—atherosclerosis	4.33e-07	4.78e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—atherosclerosis	4.08e-07	4.5e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—atherosclerosis	4.04e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—atherosclerosis	2.67e-07	2.94e-06	CbGpPWpGaD
